Andersons pediatric cardiology 1451

diagnostictestsforgroupastreptococcal
pharyngitis:ameta-analysis.Pediatrics.
2014;134:771–781.
159.CohenJF,BertilleN,CohenR,etal.Rapid
antigendetectiontestforgroupastreptococcus
inchildrenwithpharyngitis.CochraneDatabase
SystRev.2016;(7)[CD010502].
160.MartinDR,VossLM,WalkerSJ,etal.Acute
rheumaticfeverinAuckland,NewZealand:
spectrumofassociatedgroupAstreptococci
differentfromexpected.PediatrInfectDisJ.
1994;13:264–269.
161.KawakitaS,TakeuchiT,InoueJ,etal.Infection
ofgroupastreptococcusandantibodyresponse
toextracellularantigens.JpnCircJ.
1981;45:1384–1390.
162.SteerAC,VidmarS,RitikaR,etal.Normal
rangesofstreptococcalantibodytitersare
similarwhetherstreptococciareendemictothe
settingornot.ClinVaccineImmunol.
2009;16:172–175.
163.RoodpeymaS,KamailZ,ZareR.Rheumatic
fever:therelationshipbetweenclinical
manifestationsandlaboratorialtests.JPaediatr
ChildHealth.2005;41:97–100.
164.KulaS,OlguntürkR,ÖzdemirO.Twounusual
presentationsofacuterheumaticfever.Cardiol


Young.2005;15:514–516.
165.ZalzsteinE,MaorR,ZuckerN,etal.Advanced

atrioventricularconductionblockinacute
rheumaticfever.CardiolYoung.2003;13:506–
508.
166.SaraivaLR,SantosCL,AguiarIR.The
prolongationoftheQTintervalintheacute
rheumaticcarditis:anenigma.ArqBrasCardiol.
2006;87:e207–e212.
167.PolatTB,YalcinY,AkdenizC,etal.QT
dispersioninacuterheumaticfever.Cardiol
Young.2006;16:141–146.
168.ZoghbiWA,Enriquez-SaranoM,FosterE,etal.
Recommendationsforevaluationoftheseverity
ofnativevalvularregurgitationwithtwodimensionalanddopplerechocardiography.J
AmSocEchocardiogr.2003;16:777–802.
169.AmericanCollegeofCardiology/American
HeartAssociationTaskForceonPractice
Guidelines,SocietyofCardiovascular
Anesthesiologists,SocietyforCardiovascular
AngiographyandInterventions,etal.ACC/AHA
2006guidelinesforthemanagementofpatients
withvalvularheartdisease:Areportofthe
AmericancollegeofCardiology/Americanheart
associationtaskforceonpracticeguidelines
(writingcommitteetorevisethe1998guidelines


forthemanagementofpatientswithvalvular
heartdisease):developedincollaborationwith
thesocietyofcardiovascularanesthesiologists:
endorsedbythesocietyforcardiovascular

angiographyandinterventionsandthesocietyof
thoracicsurgeons.Circulation2006;114:e84–
e231.Erratumin.Circulation.2007;115:e409.
170.KinsleyRH,GirdwoodRW,MilnerS.Surgical
treatmentduringtheacutephaseofrheumatic
carditis.SurgAnnu.1981;13:299–323.
171.KinsleyRH,PocockWA.Rheumaticfeverand
rheumaticheartdisease.BarlowJB.
PerspectivesontheMitralValve.FADavis
Company:Philadelphia,PA;1987:227–245.
172.MarcusRH,SareliP,PocockWA,etal.
Functionalanatomyofseveremitral
regurgitationinactiverheumaticcarditis.AmJ
Cardiol.1989;63:577–584.
173.LemboNJ,Dell'ItaliaLJ,CrawfordMH,etal.
Mitralvalveprolapseinpatientswithprior
rheumaticfever.Circulation.1988;77:830–836.
174.ZhouL-Y,LuK.Inflammatoryvalvularprolapse
producedbyacuterheumaticcarditis:
echocardiographicanalysisof66casesofacute
rheumaticcarditis.IntJCardiol.1997;58:175–
178.
175.KamblockJ,N'GuyenL,PagisB,etal.Acute